Intravenous immunoglobulin therapy in Vogt-Koyanagi-Harada syndrome;Inmunoglobulinas en el síndrome de Vogt-Koyanagi-Harada

Neurologia

Volumn 19, Issue 7, 2004, Pages 401-403

  Gonzalez Delgado M ^a   Gonzalez C ^a   Blazquez J I ^b   Salas Puig, J ^a   Castro, J ^a   Hernandez Lahoz C ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Instituto Oftalmologico Fernandez Vega   (Spain)

Author keywords

Inmunoglobulin; Uveomeningitic syndrome; Vogt Koyanagi Harada syndrome

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; STEROID;

ADULT; ALOPECIA; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; CELLULAR IMMUNITY; DRUG MEGADOSE; GENETIC SUSCEPTIBILITY; HEADACHE; HEARING IMPAIRMENT; HUMAN; MELANOCYTE; MENINGISM; MENINGOENCEPHALITIS; PIGMENT DISORDER; PLEOCYTOSIS; RETINA DETACHMENT; TINNITUS; UVEITIS; VITILIGO; VOGT KOYANAGI SYNDROME;

ADULT; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 4944224401     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Beniz J, Forster DJ, Lean JS, Smith RE, Rao NA. Variations in clinical features of the Vogt-Koyanagi-Harada syndrome. Retina 1991;11:275-80.
2. Rubsamen PE, Gass JM. Vogt-Koyanagi-Harada syndrome: clinical course, therapy and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
3. Finsterer J, Lubec D. Reply to the letter by Solaro and Messmer Uccelli concerning the article by Finsterer and Lubec: «Persistent asetic meningitis in Vogt-Koyanagi-Harada syndrome». Eur Neural 2000;44:129-30.
4. Helveston WR, Gilmore R. Treatment of Vogt-Koyangi-Harada syndrome with intravenous immunoglobulin. Neurology 1996;46:584-5.
5. Kamondi A, Szegedi A, Papp A, Seres A, Szirmai I. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol 2000;7:719-22.
6. Read RW, Rao NA, Cunningham ET. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol 2000;11:437-42.
7. Carrasco Sánchez FJ, López Dominguez JM, Casado Chocan JL, Fernández Aparicio A. Neuritis óptica retrobulbar como forma de presentación de la enfermedad de Vogt-Koyanagi-Harada. Neurología 1998;13:369.
8. Ikeda M, Tsukagoshi H. Vogt-Koyanagi-Harada disease presenting meningoencephalitis. Eur Neurol 1992;32:83-5.
9. Bouchenaki N, Morisod L, Herbort CP. Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention. Klin Monatsbl Augenheilkd 2000;216:290-4.
10. Burton BJ, Assi A, Pavesio C. Vogt-Koyanagi-Harada syndrome presenting as a severe systemic illness. Eye 2001;15:228-9.
11. Solaro C, Messmer Uccelli M. Intravenous methylprednisolone for aseptic meningitis in Vogt-Koyanagi-Harada syndrome. Eur Neurol 2000;44:129.
12. Lubin JR, Loewenstein JI, Frederick AR. Vogt-Koyanagi-Harada syndrome with focal neurologic signs. Am J Ophthalmol 1981;91:332-41.